Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression

Lookup NU author(s): Dr Ian Brotherick, Professor Craig RobsonORCiD, Dr Jonathan Shenfine, Michael White, William Cunliffe, Dr Brian Shenton, Dr Mark Egan, Dr James Young

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Transition from a normal to a cancerous state is marked by alterations in the cytoskeletal structure of those cells involved. We have examined such changes to determine if these transitions are markers of disease progression. Cytokeratin (CK) protein and messenger RNA (mRNA) expression were examined in malignant and benign breast tissues. Flow cytometric results demonstrated a significant correlation between cytokeratin protein expression detected by 5D3 antibody, specific for cytokeratins 8, 18, and 19 and axillary node metastasis (P = 0.01). A threshold of positivity of 338,000 molecules/cell was determined and reflected the wide range in cytokeratin levels expressed by normal or benign tissues. Examination of cytokeratins 8, 18, and 19 revealed a consistent pattern of expression with respect to tumor grade. Only cytokeratin 19 showed significant correlation with increasing tumor size (P = 0.006). mRNA expression for cytokeratin 8 was significantly higher in node- positive compared with node-negative disease (P = 0.02). Cytokeratin 18 mRNA levels were significantly lower in both node-negative (P = 0.03) and node- positive (P = 0.02) patients when compared with benign samples. Increased levels of cytokeratin 18 mRNA showed an inverse relationship with protein expression (P = 0.05). The results indicate that cytokeratin expression in breast cancer may be associated with tumor progression. Furthermore, the alteration in the expression of individual cytokeratins deserves further investigation to determine the consequences of these changes with respect to cellular function.


Publication metadata

Author(s): Brotherick, I., Robson, C. N., Browell, D. A., Shenfine, J., White, M. D., Cunliffe, W. J., Shenton, B. K., Egan, M. J., Webb, L. A., Lunt, L. G., Young, J. R., Higgs, M. J.

Publication type: Article

Publication status: Published

Journal: Cytometry

Year: 1998

Volume: 32

Issue: 4

Pages: 301-308

Print publication date: 01/08/1998

ISSN (print): 0196-4763

ISSN (electronic):

URL: http://dx.doi.org/10.1002/(SICI)1097-0320(19980801)32:4<301::AID-CYTO7>3.0.CO;2-K

DOI: 10.1002/(SICI)1097-0320(19980801)32:4<301::AID-CYTO7>3.0.CO;2-K

PubMed id: 9701399


Altmetrics

Altmetrics provided by Altmetric


Share